The Company is valued around $300M right now, has zero cash, massive debt, and they have zero approved drugs anywhere in the world, and we honestly dont know for sure if the MHRA will approve DCVax or not....so yes, its priced about were it should be given the circumstances.
Question for you, now: If you had the money to do it, would you buy NWBO for $300-400m right now? Are you and I smarter than larger investors who refuse to take a large stake in NWBO? I dont think so. My DCA is about .27, I do think it will approach $1 on approval, but not much more. I will sell for a quick 200$ unless things change at the top and gives me more confidence that NWBO can execute in a timely manner. I new CEO would greatly change my mind to sell. Time will tell.
Market Data 
Markets 
AI
